EUVIMEDEUVIMED entdecken
Crossref

Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis

Daniel H Park, Han Yu, Haoling Song, Lei Ding

International Immunopharmacology · 2026-12 · 190 · 117464

DOI: 10.1016/j.intimp.2026.117464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Daniel H Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Daniel H. Park; Han Yu; Haoling Song, Lei Ding: School of Life Sciences, Yunnan University, Kunming, Yunnan 650500, China; Daniel H. Park: School of …. Hauptthemen laut MEDLINE: Methotrexate, Arthritis, Rheumatoid, Cell Adhesion Molecules, Lymphocytes. Die Arbeit nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Endothelial Junction Adhesion Molecule A (JAM-A) functionally manages immune cell infiltration via tight junctions during the pathological development of human immune diseases. However, the expression and function of JAM-A on peripheral lymphocytes are yet to be well understood. The current study aims to identify the expression and functional roles of JAM-A on peripheral lymphocyte in the context of RA treated with low-dose methotrexate (MTX). METHODS: The proportion of JAM-A+ cells in RA patients and healthy controls were detected by flow cytometry (FCM). Functional validation and the regulatory mechanism between JAM-A and integrin β1 inperipheral lymphocytes were evaluated using quantitative real-time polymerase chain reaction (RT-qPCR), bisulfite sequencing PCR (BSP-PCR), the cell adhesion assay, and MTX treatment in vitro. RESULTS: In this study, we report that JAM-A mediates lymphocytic cellular adhesion to the extracellular matrix (ECM). Knockdown of JAM-A genes or blocking cell surface JAM-A protein dimerization decreases lymphocyte adhesion to the ECM. Consistently, over-expressing JAM-A enhances lymphocytic ECM adhesion by increasing downstream adhesive proteins, namely integrin β1. In rheumatoid arthritis (RA), we found that increased proportion of JAM-A+ cells are associated with low dose MTX clinical treatments. Furthermore, treating lymphocytes with 0.01 μg/ml MTX in vitro elevates JAM-A expression by inhibiting methylation level of CpG islands in the JAM-A promotor region. In addition, we noticed that an increased level of JAM-A expression induced by low dose MTX does not directly counteract MTX's inhibitory effects on cell-to-ECM adhesion. CONCLUSION: Regardless, our findings suggest that JAM-A-mediated adhesion of lymphocytes potentially plays an important role during pathogenesis and clinical low dose MTX treatments of RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateArthritis, RheumatoidCell Adhesion MoleculesLymphocytesReceptors, Cell SurfaceAntirheumatic AgentsHumansCell AdhesionIntegrin beta1FemaleMaleMiddle AgedCells, CulturedDNA MethylationAdult

Stichwörter der Autor:innen

Cell adhesionJunction adhesion molecular AMethotrexateRheumatoid arthritis

Substanzen

MethotrexateCell Adhesion MoleculesIntegrin beta1F11R protein, humanReceptors, Cell SurfaceAntirheumatic Agents

Autor:innen und Institutionen

  • Daniel H. Park; Han Yu; Haoling Song, Lei Ding: School of Life Sciences, Yunnan University, Kunming, Yunnan 650500, China; Daniel H. Park: School of Medicine, The University of Kansas Medical Center, Kansas City, Kansas…
  • Daniel H. Park; Han Yu; Haoling Song, Lei Ding: School of Life Sciences, Yunnan University, Kunming, Yunnan 650500, China.
  • Daniel H. Park; Han Yu; Haoling Song, Lei Ding: School of Life Sciences, Yunnan University, Kunming, Yunnan 650500, China. Electronic address: dingleiynu@ynu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Park, D. H., Yu, H., Song, H., & Ding, L. (2026). Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis. International Immunopharmacology, 190, 117464. https://doi.org/10.1016/j.intimp.2026.117464

Vancouver

Park DH, Yu H, Song H, Ding L. Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis. International Immunopharmacology. 2026;190:117464. doi:10.1016/j.intimp.2026.117464

BibTeX
@article{Park2026,
  author = {Park, Daniel H and Yu, Han and Song, Haoling and Ding, Lei},
  title = {Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {190},
  pages = {117464},
  doi = {10.1016/j.intimp.2026.117464}
}
Kostenlos starten →